Dr Angela Thomas has been appointed as vice-chair of the Commission on Human Medicines (CHM). She replaces Professor Ian Weller who retired from the position and from CHM on 31 December 2014.

The CHM advises on matters relating to safety, quality and the efficacy of medicines as well as the collection of adverse drug reactions.

Dr Angela Thomas is a consultant paediatric haematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former President of the British Society for Haematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group.

She has also served as a member and chaired many scientific and medical committees in the UK and Europe.

Dr Angela Thomas said:

“I am delighted to be taking up this new role. The Commission plays a vital role in the licensing of new medicines and in monitoring drug safety.

“I have found my time as a member of CHM tremendously rewarding and am looking forward to the challenges offered in my new role as vice-chair.”



Posted on the UK MHRA website on 19 January 2015